Firefly Neuroscience terminated its securities purchase agreement with an accredited investor that provided for the sale of up to 666,667 units at $1.50 per unit, for gross proceeds of up to $1,000,000. The parties mutually agreed in writing to end the agreement effective June 25, 2026, pursuant to Section 5.3. No termination fees or payments were disclosed. The decision removes a previously planned near-term financing source.
Agreement details:
- Agreement terminated: Securities purchase agreement for units financing
- Counterparty: Accredited investor
- Original agreement date: May 06 2026
- Termination date: Jun 25 2026
- Termination type: mutual
- Exit fees / payments: None
- Reason: Parties mutually elected to terminate the financing
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.